InvestorGlobal private investment firm with diverse strategies.

Clarus Funds, now operating as Blackstone Life Sciences, focuses on late-stage life sciences investments, particularly in biopharmaceuticals and medical technologies. The organization collaborates with major pharmaceutical companies to fund and develop innovative therapies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Clarus Funds, part of Blackstone Life Sciences, specializes in late-stage investments in the life sciences sector, particularly in the development of medicines and technologies. Founded in 2005, the organization collaborates with pharmaceutical, biotech, and medical technology companies to address unmet medical needs. Their investment strategy emphasizes funding innovative core products from credible counterparties, aiming for market-unrelated returns at lower risk. Notable collaborations include significant partnerships with Moderna and Alnylam Pharmaceuticals, reflecting their commitment to advancing healthcare solutions.
Clarus Funds primarily invests in late-stage life science products and companies, focusing on funding the development of innovative core products from credible counterparties. Their strategy aims to generate market-unrelated returns at lower risk, with a strong emphasis on collaboration across various therapeutic areas within the life sciences sector.
Clarus Funds adds value to its portfolio companies through strategic collaborations, funding for R&D, and leveraging its extensive network within the pharmaceutical and biotech industries to facilitate the development and commercialization of innovative therapies.
Clarus Funds primarily invests in late-stage life science products and companies, focusing on Series C and Series D funding rounds. They seek innovative core products from credible counterparties that address significant medical needs.
Founders can submit their pitches through the Clarus Funds website at clarusfunds.com. It is recommended to include detailed information about the product, market potential, and the team.
Clarus Funds specializes in the life sciences sector and has a strong focus on late-stage investments. Their affiliation with Blackstone Life Sciences provides them with extensive resources and expertise in funding and executing clinical trials.
Clarus Funds primarily operates in the United States but is open to opportunities in other regions, particularly where innovative life sciences products are being developed.
Clarus Funds actively engages with portfolio companies, offering operational support and strategic guidance to help them navigate the complexities of bringing their products to market.
Clarus Funds typically invests significant amounts in late-stage rounds, with check sizes varying based on the specific needs of the portfolio company and the stage of development.
Superscout Pro
Is this page right?Reviewed · How the research works